8 Dec 2025

Reference: CIR-2025-00000228

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated.

Awareness Circular – Detection of Falsified Cagrilintide Product in International Markets

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Circular no. 20 - Awareness Circular – Detection of Falsified Cagrilintide Product in International Markets.pdf

download